Background. Mutations in the aquaporin-2 (AQP2) gene cause nephrogenic diabetes insipidus (NDI), a renal disorder characterized by polyuria due to a lacking antidiuretic response to vasopressin. While most AQP2 mutants in recessive NDI are misfolded and retained in the endoplasmic reticulum, AQP2-P262L in NDI was impaired in its vasopressin-dependent translocation from vesicles to the plasma membrane. Methods. Vasopressin-induced translocation of AQP2 coincides with AQP2 phosphorylation at S256, S264 and T269 and dephosphorylation at S261. Since P262 lies adjacent to S261, we tested whether a changed phosphorylation could underlie AQP-P262L missorting in NDI. Results. In polarized cells, AQP2-P262L expressed as a double 29/30 kDa band, whereas wt-AQP2 expressed only as a 29 kDa band. Phosphatase treatment revealed that the 30 kDa AQP2-P262L band was due to changed phosphorylation. The use of newly developed phospho-specific antibodies showed that forskolin not only increased pS256 and pT269, but, in contrast to wt-AQP2, also pS261 in AQP2-P262L. The expression of AQP2-P262L proteins in which S261 phosphorylation was prevented (S261A), however, was still missorted to vesicles/basolateral membrane, despite the absence of the 30 kDa band. Conclusions. Together, our data reveal that vasopressin induces instead of reduces the phosphorylation of S261 in AQP2-P262L, but it remains to be established whether the changed phosphorylation causes its missorting in NDI.
Introduction
The kidney is the main organ for the regulation of water homeostasis. Of the 180 L of pro-urine produced daily, 90% of the water is constitutively reabsorbed in the renal proximal tubules and descending thin limbs of Henle. This massive reabsorption has been attributed to the aquaporin-1 (AQP1) water channel, which is expressed in the apical and basolateral membranes of the epithelial cells that line these nephron segments. The remaining 10% can be reabsorbed in collecting ducts via aquaporin-2 (AQP2). This is under control of the antidiuretic hormone arginine vasopressin (AVP), which is released from the pituitary gland after sensing hypernatraemia or hypovolaemia [1] . AVP binds to its G-protein-coupled V2 receptor (V2R) in the basolateral membrane of the principal cells. This binding triggers a cyclic AMP (cAMP) signalling cascade which leads to protein kinase A (PKA) activation and changes in phosphorylation of the water channel AQP2. Consequently, AQP2 is redistributed from intracellular vesicles to the apical membrane, and water is able to pass the apical membrane passively along an osmotic gradient and enters the blood via AQP3 and AQP4 water channels, which are constitutively expressed in the basolateral membrane [2] [3] [4] .
In patients suffering from congenital nephrogenic diabetes insipidus (NDI), this mechanism is impaired, resulting in a severe loss of water. NDI is caused by mutations in the gene encoding V2R, which comprises the X-linked form, or in AQP2, which results in the autosomal recessive and dominant forms of NDI [5] . AQP2 mutants in dominant NDI are functional water channels, but are sorted to other subcellular organelles than wild-type (wt)-AQP2. As AQP2 is expressed as a homotetramer and these AQP2 mutants are properly folded in the endoplasmic reticulum (ER), they form heterotetramers with wt-AQP2 and missort the wt/mutant-AQP2 complexes [6, 7] . The resulting lack of sufficient levels of wt-AQP2 in the apical membrane of collecting duct cells provides an explanation for dominant NDI. In contrast to most mutants in recessive NDI [8, 9] , AQP2 mutations found in dominant NDI are located in the C-terminal tail (P225-A271), which underscores the importance of this part of the protein in AQP2 sorting [10] [11] [12] [13] .
De Mattia et al. [14] reported two families with recessive NDI who were compound heterozygote for AQP2-A190T or AQP2-R187C mutants, together with AQP2-P262L. AQP2-A190T and AQP2-R187C are classical mutants in recessive NDI, resulting in misfolded proteins and retention in the ER [8, 14, 15] . As mutations in the AQP2-C-tail, where P262 resides, usually cause dominant NDI, the underlying cell biological mechanism was investigated [14] . Similar to AQP2 mutants in dominant NDI, AQP2-P262L was a properly folded and functional water channel. Yet, upon expression in polarized cells, AQP2-P262L was missorted, as it was retained in intracellular vesicles upon forskolin treatment. Upon coexpression with wt-AQP2, however, the apical membrane expression of AQP2-P262L was rescued because of its heterotetramerization with wt-AQP2. At present, it is unclear which molecular mechanism is fundamental to the retention of AQP2-P262L.
Plasma membrane expression of AQP2 is regulated by phosphorylation. Vasopressin-induced PKA activation phosphorylates AQP2 at S256 in the C-tail which is essential for the plasma membrane expression [16, 17] . Vasopressin also triggers the phosphorylation of S264 and S269 in AQP2 [18, 19] . In vitro and in vivo studies revealed that pS256 is the priming phosphorylation step for pS264 and pS269 and that all three sites are found phosphorylated in AQP2 localized at the plasma membrane [20] . In contrast to the sites above, S261 in AQP2 is highly phosphorylated when unstimulated, but is de-phosphorylated upon treatment with vasopressin [20] . Regulation of S261 phosphorylation by a member of the so-called 'proline-directed' seine/threonine kinase subfamily has been suggested because these kinases are inactivated in the renal collecting duct by vasopressin and S261 is flanked by proline 262 [21] . As this site is mutated in AQP2-P262L, we investigated whether the P262L mutation affects AQP2 phosphorylation and whether this could underlie the missorting of AQP2-P262L.
Methods

Cells and constructs
Stably transfected mouse cortical collecting duct (mpkCCD) and Madin-Darby canine kidney (MDCK) cells were cultured as described [22, 23] . Cells were seeded at a density of 1. The generation of pCB6-AQP2-P262L and transfection in the MDCK type I cell line were done as described [14] . The same construct was used to generate stably transfected mpkCCD cells. To generate pCB6-AQP2-S261A-P262L, mutagenesis was performed using the Altered Sites II in vitro mutagenesis kit (Promega, Madison, WI) on pT7Ts-AQP2-P262L [14] using sense primer AQP2-1 (for all primer sequences, see Table 1 ) and the antisense counterpart. The mutated fragment was then digested with BamHI and StuI and ligated into pCB6ΔBHI-AQP2 [14] to generate pCB6ΔBHI-AQP2-S261A-P262L.
To generate pCB6-AQP2-S256D-S261A/D-P262P/L-S264D-T269E, pCB6ΔBHI-AQP2-S261D-S264D-T269E construct was first made using mutagenesis with Primer 2 and its antisense counterpart and followed by Primer 3 and its antisense counterpart, after which the mutated fragment was digested with BamHI and StuI and ligated into pCB6ΔBHI-AQP2. The S256D mutation was introduced using a three-point polymerase chain reaction (PCR) with Primers 4, 5 and 6. Then, the S261A/D-P262P/L mutations were introduced using a 3-point PCR with Primers 4, 5 and either 7, 8 or 9 using pCB6ΔBHI-AQP2-S256D-S261D-S264D-T269E as a template. Introduction of only the desired mutations was checked by sequence analysis. Stably transfected pooled colonies of mpkCCD and MDCK cells or mpkCCD clones (for AQP2-P262L only) were selected and cultured in the presence of 0.5 mg/mL (mpkCCD) or 0.8 mg/mL G418 (MDCK) (Sigma). Proper localization and expression of AQP2-P262L in mpkCCD clones was confirmed by analysis of at least four independent clones.
Antibodies and peptides
For the detection of total AQP2 on immunoblot and immunocytochemistry without the influence of phosphorylation of any of the sites in AQP2-C-tail, antibodies were raised in rabbits against a peptide covering aa236-255 (LKGLEPDTDWEEREVRRRQ) of human AQP2 C-terminus ( pre-C-tail). To detect phosphorylated AQP2 at S256, S264 and S269, rabbits were immunized with phosphorylated peptides EVRRRQ ( pS)VELHSP, C-ELHSPQ(pS)LPRGSK and C-HSPQSLPRG( pS)KA, respectively (Eurogentec, Maastricht, the Netherlands; C indicates cystein-coupled). To purify the phospho-specific antibodies form the rabbit serum, the phosho-specific peptides and the corresponding nonphospho peptides were coupled to activated CH sepharose 4A (for S256) or thiol-sepharose beads 4B (in the case of S264 and S269) (Sigma). The serum was incubated with the beads coupled to the phospho-specific peptides and the bound antibodies were eluted with 200 mM glycine, pH 2.8 (Sigma). Then, the eluted antibodies were incubated with the beads coupled to the non-phospho-peptides. The flow through, containing the phospho-specific antibodies, was collected. Phospho-specificity of the antibodies was determined with enzyme-linked immunosorbent assay and dot blots using the phosphorylated and non-phosphorylated peptides as antigens. Immunization of rabbits was done by Eurogentec. Antibodies recognizing AQP2-pS261 were purchased from Novus Biological, Cambridge, UK.
To verify the influence of the amino acid mutation on the affinity of the antibody against AQP2-pS261, biotinylated peptides of the C-tail of wt-AQP2 or AQP2-P262L (aa242-271) with or without phosphorylated S256, S261 and S264 were made as described [25] . The identity of peptides was confirmed by mass spectrometry, and their purities were >80% as determined by high-pressure liquid chromatography analysis (220 nm).
De-phosphorylation, immunoblot and dot blot
For immunoblotting, mpkCCD and MDCK cells from 12-well filters (1.13 cm 2 ) were lysed in 200 µL laemmli buffer, containing 0.1 M dithiothreitol (DTT) (MP Biomedicals, Illkirch, France), 1 mM phenylmethlysulfonyl fluoride (PMSF; Sigma), 5 µg/mL pepstatin, leupeptin and aprotinin (all MP Biomedicals), 10 mM NaF, 0.5 mM Na 3 VO 4 , 20 mM NEM (all Sigma). Samples were sonicated to shear chromosomal DNA.
Samples used for de-phosphorylation were harvested in 200 μL lysis buffer (150 mM NaCl, 25 mM HEPES, 1% Triton) supplemented with protease inhibitors (PMSF, aprotinin, leupeptin, pepstatin) and de-ubiquitination inhibitor (20 mM NEM) and divided into three aliquots, which were treated as follows: phosphatase inhibitors (10 mM NaF, 0.5 mM Na 3 VO 4 ), alkaline phosphatase (0.1 U/µL cell lysate) (Roche, Mannheim, Germany) or no additional treatment. Samples were incubated for 30 min at 37°C. Afterwards, laemmli buffer was added and DTT to a final concentration of 0.1 M.
For immunoblotting, proteins of all samples were denatured by incubation at 37°C for 30 min. Polyacrylamide gel electrophoresis (PAGE), blotting and blocking of the PVDF membranes was done as described [7] . Membranes were incubated for 16 h at 4°C with 1:1000-diluted primary antibodies in TBST supplemented with 1% non-fat dried milk (NFDM) followed by a 1 h incubation with 1:10 000-diluted goat antirabbit IgGs in 1% NFDM in TBST, coupled to horseradish peroxidase (Sigma). Proteins were visualized using enhanced chemiluminescence (ECL, Pierce, Rockford, IL).
For dot blotting, peptides (5 µg) were dotted on PVDF membranes (Millipore, Billerica, MA, USA). The membranes were blocked with 5% NFDM in TBST and incubated with the 1:1000-diluted antibody for 2 h at RT in 1% NFDM in TBST. After washing, membranes were incubated for 1 h at RT with the 1:10000-diluted goat anti-rabbit peroxidasecoupled secondary antibody and visualized with enhanced chemiluminescence (ECL). To confirm dotting of equal amounts of the used peptides, identical volumes of the peptide solutions were dotted and incubated with peroxidase-coupled streptavidin (Jackson ImmunoResearch, West Grove, PA) and analysed as above.
Immunocytochemistry
Immunocytochemistry was done as described [23] . Briefly, mpkCCD cells cultured on filter and treated as described above were washed once with phosphate-buffered saline (PBS) and fixed in 4% paraformaldehyde in PBS for 30 min. Cells were permeabilized with 0.3% Triton in PBS and quenched with 50 mM NH 4 Cl in PBS for 15 min. Blocking was achieved by incubation with 16% goat serum diluted in PBS with 0.3% Triton [goat serum dilution buffer (GSDB)]. Incubation with rabbit-AQP2 antibodies ( pre-C-tail) was done overnight (1:100 in GSDB) at 4°C
. The secondary antibody anti-rabbit-Alexa488 (Sigma) was incubated for 1 h at room temperature (1:100 in GSDB). Pictures were taken with the Olympus FV1000 confocal laser scanning microscope.
Results
Upper band of AQP2-P262L is related to phosphorylation
Earlier, we reported that besides the unglycosylated 29 kDa and complex glycosylated 40-45 kDa bands observed for wt-AQP2, AQP2-P262L was expressed as a 30 kDa band [14] . As this post-translational modification could underlie its missorting, we investigated its nature. High-mannose glycosylated AQP2, which is typical for AQP2 mutants in recessive NDI localized in the ER, runs at 32 kDa. To test whether the upper band could represent high-mannose glycosylated AQP2, lysates of MDCK cells expressing wt-AQP2, AQP2-P262L or the ER-retained mutant found in the NDI patient co-expressed with AQP2-P262L, AQP2-A190T, were treated with endoglycosidase H (endo H), which specifically cuts off highmannose glycosylation. In contrast to the 32 kDa band of AQP2-190T, endo H treatment did not remove the 30 kDa band of AQP2-P262L ( Figure 1A ). As anticipated for proper processed wt-AQP2 in stably transfected MDCK cells, an abundant 29 kDa, but no 30 or 32 kDa bands were observed for wt-AQP2.
As the C-tail of AQP2 is extensively phosphorylated, we next investigated whether the 30 kDa band was due to a changed phosphorylation when compared with wt-AQP2. For this, MDCK-AQP2-P262L and MDCK-AQP2 1  S261A-P262L  cggtggagctacacgccctgcagagcctgcc  2  S261D  cggtggagctacacgacccgcagagcctgcc  3  S261D-S264D-T269E  cacgacccgcaagatctgccacggggtgaaaaggcctgaggg  4  AQP2-1  atgtgggagctccgctccatagc  5  pCB6 antisense  cactggagtggcaacttcc  6  S256D  gtgcgacggcggcaggacgtcgagctgcacgacccgc  7  S261D-P262L-S264D  cgtcgagctgcacgacctgcaggatctgccacggggtg  8  S256D-S261A-S264D  gcggcaggacgtcgagctacacgccccgcaagatctgccacg  9 S256D-S261A-P262L-S264D gcggcaggacgtcgagctacacgccctgcaggatctgccacg
Mutations are shown in bold letters, silent mutations to introduce restriction sites are underlined.
Increased S261 phosphorylation in AQP2-P262Lcells, pre-treated with forskolin or dDAVP, were lysed and treated with alkaline phosphatase, phosphatase inhibitors or left untreated and subjected to immunoblotting. As shown ( Figure 1B) , the phosphatase treatment specifically abolishes the 30 kDa band with a concomitant increase of the 29 kDa band (Ph) in comparison to untreated (C) or protected (Ph in , phosphatase inhibitor) conditions. As anticipated, no changes were observed for wt-AQP2. These data illustrate that the 30 kDa band of AQP2-P262L comes from a changed phosphorylation when compared with wt-AQP2.
Generation and characterization of phospho-specific AQP2 antibodies
To investigate changes in AQP2 phosphorylation, antibodies were generated recognizing pS256, pS261, pS264 and pS269. Dot blot analysis of phosphorylated and nonphosphorylated C-terminal peptides of AQP2 revealed that these antibodies specifically recognize the phosphorylated peptides (Figure 2A ). Moreover, they did not bind to the peptides phosphorylated or not at the neighbouring phosphorylation sites. Of note, as our pS261 antibody did not show binding, a commercial antibody was obtained. S269 in mouse and rat AQP2 is replaced by a threonine in human AQP2. To test whether our pS269-directed antibodies also recognize pT269, we tested our antibodies against hAQP2 or hAQP2-T269S stably expressed in MDCK cells. Interestingly, and in contrast to existing pS269 antibodies, our pS269 antibodies recognized pT269 as well as pS269, because a clearly increased signal for hAQP2 and hAQP2-T269S was detected upon dDAVP treatment ( Figure 2B ), a condition known to increase S269 phosphorylation [20] . Similar data were obtained upon treatment with forskolin (data not shown).
In contrast to wt-AQP2, forskolin increases AQP2-P262L phosphorylation at S261
Next, we tested whether forskolin-induced phosphorylation of AQP2-P262L differed from that of wt-AQP2. In line with earlier studies [20] , activation of the PKA pathway with forskolin in MDCK-AQP2 cells increased pS256 and pT269 and decreased pS261 ( Figure 3 , left panel). In line with the data for wt-AQP2, forskolin also increased pS256 and pT269 in AQP2-P262L. In contrast to wt-AQP2, however, forskolin also increased pS261 in AQP2-P262L. Moreover, using total AQP2 antibodies, the 30 kDa signal became more intense with forskolin, which indicated that phosphorylation events induced by forskolin underlies the appearance of the 30 kDa AQP2-P262L band. Indeed, while with total AQP2 detection, the signal for the upper band of AQP2-P262L with forskolin treatment was still weaker than that of the 29 kDa band, staining for pS256 or pS261 revealed a stronger signal for 30 than for 29 kDa AQP2-P262L, suggesting that the existence of the 30 kDa band is mainly due to the pS256 and/or pT269 combined with S261 phosphorylation. Our antibodies against pS264 did not reveal a specific band for wt-AQP2 or AQP2-P262L (data not shown) and was therefore left out for further analysis.
A prerequisite for our statement that forskolin increases pS261 in AQP2-P262L is that the increased binding of the pS261-AQP2 antibody is indeed due to increased phosphorylation of S261 in AQP2-P262L and not due to a P262L-induced conformational change leading to a better binding of the pS261 antibody. To test this, biotincoupled peptides of the C-tail of AQP2 and AQP2-P262L, phosphorylated at different sites, were made, spotted on a membrane and incubated with AQP2-pS261 antibodies or with streptavidin-horseradish peroxidase (HRP) to check for total peptide loading (Figure 4) . Indeed, the AQP2-pS261 antibody recognized wt-AQP2 and AQP2-P262L phosphorylated at S261, as well as AQP2-P262L phosphorylated at both S256 and S261. Moreover, no cross reactivity was found with non-phosphorylated peptides or the P262L peptide phosphorylated at serine 256 or 264 only.
Altogether, these data reveal that in contrast to wt-AQP2, forskolin induces phosphorylation of S261 in AQP2-P262L and this difference in pS261 may underlie the missorting of AQP2-P262L in NDI. 
Mimicking de-phosphorylation at serine 261 does not correct the missorting of AQP2-P262L
Changing a serine into an alanine or aspartate often mimics constitutive de-phosphorylation or phosphorylation, respectively [26] . In contrast to in vivo [27] , however, AQP2-S261A and AQP2-S261D are retained in vesicles in MDCK cells, independent of forskolin stimulation [28] . Therefore, to investigate the role of S261 phosphorylation in AQP2-P262L missorting, we turned to the mouse kidney collecting duct mpkCCD cell model.
Indeed, mpkCCD cells showed a forskolin-induced redistribution of wt-AQP2 and hAQP2-S261A from vesicles to the apical membrane ( Figure 5A , upper and middle panels). Similar to MDCK cells, AQP2-P262L localized in vesicles and basolateral membrane without stimulation and translocated to a larger extent to the basolateral membrane with forskolin ( Figure 5A, lower panel) . Immunoblot analysis further showed that also in these cells, AQP2-P262L is expressed as a 29 and 30 kDa band, of which the 30 kDa band was increased in its intensity with forskolin treatment, whereas wt-AQP2 only showed the 29 kDa band ( Figure 5B) .
If, in addition to the increase in phosphorylation at S256, S264 and T269 with forskolin, the increase in pS261 is the cause of AQP2-P262L missorting, it was anticipated that changing S261 into alanine should rescue AQP2-P262L missorting. To test this, mpkCCD cells stably expressing AQP2-S261A-P262L were generated and left untreated or treated with forskolin. Consistent with the necessity of S261 phosphorylation for the appearance of the 30 kDa band, AQP2-S261A-P262L was only expressed as a 29 kDa band ( Figure 6A ). Immunocytochemistry, however, revealed that AQP2-S261A-P262L was still sorted to the basolateral membrane ( Figure 6B ).
To secure that S256, S264 and T269 were phosphorylated, we subsequently generated wt-AQP2 and AQP2-P262L expression constructs in which, besides changes of S261 into alanine or aspartate, S256, S264 and T269 were changed into aspartic/glutamic acid to mimic constitutive phosphorylation. Again, in line with the need for S261 phosphorylation for the appearance of the 30 kDa band, the S256D-S264D-T269E forms of wt-AQP2 and AQP2-P262L with S261A ran about 1 kDa lower than with S261D and these masses were not changed with forskolin ( Figure 7A) . Immunocytochemistry, however, revealed that also AQP2-P262L-S256D-S261A-S264D-T269E localized in intracellular vesicles and the lateral membrane, whereas the corresponding wt-AQP2 protein (AQP2-S256D-S261A-S264D-T269E) localized in the apical membrane in the presence ( Figure 7B ), but also in the absence (data not shown) of forskolin. These data indicated that also when all phosphorylation sites mimic the AVP-stimulated state, the prevention of S261 phosphorylation does not rescue the missorting of AQP2-P262L. 
Discussion
The P262L mutation leads to increased S261 phosphorylation Our data provide compelling evidence that the change of P262 into a leucine in AQP2, as found in two of our NDI patients, leads to an increase instead of a decrease in S261 phosphorylation upon stimulation of the PKA pathway. At first, AQP2-P262L expressed in MDCK and mpkCCD shows, besides the expected 29 kDa band, a 30 kDa band which disappeared upon treatment with phosphatases and increased in intensity following treatment with forskolin. Secondly, while detailed analysis using phospho-specific antibodies revealed that forskolin increased pS256 and pT269 in wt-AQP2 and AQP2-P262L, forskolin only increased the pS261 signal in AQP2-P262L. Antibody binding to specific peptides revealed that this increase in pS261 signal was indeed a result of increased S261 phosphorylation and not due to a P262L-induced change in conformation. Thirdly, in contrast to AQP2-P262L, the 30 kDa band was absent for AQP2-S261A-P262L expressed in mpkCCD cells and, fourthly, wt-AQP2 as well as AQP2-P262L in which S256, S264 and T269 were all changed to mimic constitutive phosphorylation ran as a 30 kDa band when S261 was changed into an aspartate, but as a 29 kDa when S261 was changed into an alanine.
The nature of the 30 kDa AQP2-P262L band
Although pS261 is essential, our data reveal that S261 phosphorylation is not sufficient for the appearance of the were fixed, stained with anti-AQP2 antibodies and subjected to confocal laser scanning microscopy to determine AQP2 localization. 30 kDa band, as unstimulated wt-AQP2 is mainly phosphorylated at S261, but is expressed as a 29 kDa band (e.g. Figure 3 ). Instead, our data indicate that the AQP2 protein should also be phosphorylated at S256, S264 and/ or T269 besides pS261, as the relative increase in 30 kDa AQP2-P262L coincides with phosphorylation of all these sites (Figure 3) . Moreover, wt-AQP2 and AQP2-P262L already have a reduced electrophoretic mobility without forskolin, when S256/261/264 and 269 are substituted by amino acids that mimic their phosphorylation ( Figure 7A ). Our data do not reveal which combination of S256, S264 and T269 phosphorylation is, besides pS261, needed for the 30 kDa band.
The reduced electrophoretic mobility of AQP2-P262L (30 kDa) may be caused by the difference in charge because all proteins with a reduced electrophoretic mobility can have four (mimicked) phosphorylated sites, whereas those with less sites phosphorylated have an increased mobility (29 kDa). However, as one more negative charge does not make up for a 1 kDa difference in mass and a more negative protein is anticipated to have an increased instead of decreased mobility in PAGE, it is more likely that the different mobility is due to a changed structure, because of S261 and the other phosphorylation events described above. Indeed, AQP2-S256D-S261D-S264D-T269E and AQP2-S256D-S261A-S264D-T269E have a different mobility, but have similar masses (28.95 versus 28.91 kDa). Similarly, the different running patterns of AQP2-E258K variants could also not be explained by differences in their masses [12, 13] . Moreover, studies using circular dichroism showed that the secondary structure of non-phosphorylated peptides of the AQP2 C-terminus differs from the structure of peptides phosphorylated at S256 or S261 [29] .
Kinases and phosphatases regulating S261 phosphorylation
The kinase responsible for phosphorylation at S261 is not known so far, but the proline next to the serine suggests that proline-directed kinases, like MAP-kinases, could play a role. Indeed, in line with pS261 changes in wt-AQP2, mass spectrometry-based phospho-proteomics revealed that dDAVP stimulation decreased phosphorylation activity of several proline-directed kinases and phosphorylation of AQP2 at S261 could be demonstrated by in vitro incubation of the synthetic C-terminus of AQP2 with proline-directed kinases, such as JNK, p38alpha, CDK1 and CDK5 [21] . Alternatively, the increased pS261 in wt-AQP2 of unstimulated principal cells could be due to inactivated phosphatases.
The exchange of the proline into a leucine at amino acid 262 in AQP2-P262L results in a disturbed motif for proline-directed kinases and, in line with this, phosphorylation of S261 in AQP2-P262L is changed when compared with wt-AQP2. Surprisingly, however, forskolin increases pS261 in AQP2-P262L, suggesting that the loss of P262 and/or introduction of the leucine introduces a motif for another kinase or phosphatase, which is activated via the PKA pathway. Using bio-informatical algorithms, however, no kinase is predicted to act on this particular site in AQP2-P262L (Table 2 ) [30] . The identity of the kinase or phosphatase acting on S261 in AQP2-P262L remains to be established.
Role of changed S261 phosphorylation in AQP2-P262L missorting
Our cell biological data do not support a role for this change in the missorting of AQP2-P262L. Despite the clearly reversed correlation of S261 phosphorylation in AQP2-P262L with forskolin when compared with wt-AQP2 with all the different constructs generated, the prevention of S261 phosphorylation in different AQP2-P262L proteins (AQP2-S261A-P262L and AQP2 -S256D-S261A-P262L-S264D-T269E) did not correct its missorting in mpkCCD cells. These data are in line with the finding that in most cell systems, including our mpkCCD cells ( Figure 5 ), constitutive mimicking of S261 phosphorylation or de-phosphorylation with S261A/D mutations did not affect the trafficking of AQP2 to the apical membrane of polarized cells [31, 32] . Thus, while pS261 in wt-AQP2 is restricted to vesicularly localized AQP2 [27] , possibly suggesting the role of S261 phosphorylation in AQP2 trafficking, such a role does not become apparent for wt-AQP2 or AQP2-P262L from cell culture studies.
Based on our data, it may be more likely that the introduced leucine is causal for AQP2-P262L to be involved in NDI. Leucines are known to play a role in sorting motifs and a known basolateral sorting motif is the double leucine motif often with an acidic region a few amino acids upstream of it [33] . However, not only a double leucine motif can serve as a signalling motif, as also single leucines have been shown to redirect proteins. For the stem cell factor and CD147, it has been shown that one critical leucine is sufficient for its basolateral sorting in MDCK cells [34, 35] . In line with this hypothesis, AQP2-P262A did traffick to the apical membrane [14] . Unfortunately, our pS261 antibodies did not yield any signal with AQP2-P262A (data not shown), which could be interpreted that this AQP2 variant is not phosphorylated at S261 following forskolin, indicating to a possible role for pS261 in AQP2-P262L missorting, or that the pS261 antibodies do not bind pS261 in AQP2-P262A.
In conclusion, while the exchange of a leucine for P262 may be most likely to underlie AQP2-P262L missorting in vivo, a role for S261 phosphorylation in its missorting cannot be fully excluded at present. Mouse transgenesis will be necessary to possibly uncover a role for S261 phosphorylation in the normal trafficking of wt-AQP2 and the missorting of AQP2-P262L in NDI. 
